The West Clinic, P.C. ( Site 0791), Germantown
Thompson Cancer Survival Center ( Site 0803), Knoxville
Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0831), Nashville

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Sarah Cannon Research Institute, Nashville
SCRI Oncology Partners, Nashville
Tennessee Oncology, Nashville

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Sarah Cannon Research Institute, Nashville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05267626

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

SCRI, Nashville
Vanderbilt-Ingram Cancer Center, Nashville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07217171

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Sarah Cannon Research Institute, Nashville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

The Conrad Pearson Clinic (Urology America), Germantown
Urology Associates, PC, Nashville

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Conrad Person Clinic, Memphis
Urology Associates PC, Nashville

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Sarah Cannon and HCA Research Institute, Nashville
Tennessee Oncology, Nashville
Vanderbilt University Medical Center, Nashville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Nashville

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07129993

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Vanderbilt Breast Center at One Hundred Oaks, Nashville
Vanderbilt University/Ingram Cancer Center, Nashville

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Urology Associates, P.C., Nashville
Vanderbilt Univerity Medical Center, Nashville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Vanderbilt University Medical Center, Nashville

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07225127

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

SCRI Oncology Partners, Nashville
Local Institution - 0084, Nashville

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

SCRI - TriStar Medical Group Children's Specialists, Nashville
SCRI Oncology Partners, Nashville

Mengambil pesertaFasa 2

Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Nashville

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

University of Tennessee Medical Center, Knoxville

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

US Oncology Research LLC, Nashville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Vanderbilt University Medical Center, Nashville

Mengambil peserta

Umur 18 hingga 88 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06394869

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
Vanderbilt University Medical Center, Nashville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Baptist (BHMCC), Memphis
Vanderbilt-Ingram Cancer Center, Nashville

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Memphis
Massive Bio SYNERGY-AI site, Nashville

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.